Panagora Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-18,185
Closed -$659K 1466
2023
Q1
$659K Buy
+18,185
New +$659K ﹤0.01% 1017
2021
Q3
Sell
-142
Closed -$4K 2326
2021
Q2
$4K Sell
142
-4,321
-97% -$122K ﹤0.01% 2540
2021
Q1
$117K Sell
4,463
-29,071
-87% -$762K ﹤0.01% 1929
2020
Q4
$844K Sell
33,534
-10,635
-24% -$268K 0.01% 1040
2020
Q3
$920K Sell
44,169
-152,183
-78% -$3.17M 0.01% 931
2020
Q2
$4.66M Buy
196,352
+62,310
+46% +$1.48M 0.03% 423
2020
Q1
$2.41M Sell
134,042
-227,209
-63% -$4.09M 0.02% 539
2019
Q4
$8.57M Buy
361,251
+18,252
+5% +$433K 0.04% 359
2019
Q3
$9.43M Sell
342,999
-23,004
-6% -$632K 0.04% 341
2019
Q2
$12.1M Sell
366,003
-7,480
-2% -$248K 0.05% 304
2019
Q1
$13.1M Buy
373,483
+126,743
+51% +$4.44M 0.06% 298
2018
Q4
$8.2M Buy
246,740
+3,557
+1% +$118K 0.04% 353
2018
Q3
$12.2M Sell
243,183
-1,538
-0.6% -$77.4K 0.05% 322
2018
Q2
$14.6M Sell
244,721
-11,319
-4% -$677K 0.06% 275
2018
Q1
$11.7M Sell
256,040
-6,125
-2% -$281K 0.05% 328
2017
Q4
$10.4M Sell
262,165
-4,490
-2% -$179K 0.04% 381
2017
Q3
$10.7M Sell
266,655
-141,638
-35% -$5.67M 0.04% 389
2017
Q2
$17.6M Buy
408,293
+100,653
+33% +$4.34M 0.07% 273
2017
Q1
$9.63M Sell
307,640
-586
-0.2% -$18.3K 0.04% 428
2016
Q4
$7.78M Buy
308,226
+1,359
+0.4% +$34.3K 0.04% 433
2016
Q3
$7.59M Sell
306,867
-23,810
-7% -$589K 0.04% 431
2016
Q2
$6.74M Buy
330,677
+27,805
+9% +$566K 0.03% 463
2016
Q1
$4.62M Buy
302,872
+72,517
+31% +$1.11M 0.02% 601
2015
Q4
$3.1M Buy
230,355
+33,294
+17% +$447K 0.02% 677
2015
Q3
$2.77M Sell
197,061
-16,115
-8% -$226K 0.01% 669
2015
Q2
$3.62M Sell
213,176
-20,308
-9% -$345K 0.02% 609
2015
Q1
$2.82M Buy
233,484
+95,499
+69% +$1.15M 0.01% 669
2014
Q4
$1.15M Sell
137,985
-1,026
-0.7% -$8.51K 0.01% 988
2014
Q3
$1.21M Sell
139,011
-7,291
-5% -$63.4K 0.01% 956
2014
Q2
$1.6M Buy
146,302
+7,391
+5% +$80.9K 0.01% 897
2014
Q1
$1.24M Sell
138,911
-1,145
-0.8% -$10.2K 0.01% 1084
2013
Q4
$1.06M Buy
140,056
+1,700
+1% +$12.8K ﹤0.01% 1154
2013
Q3
$1.01M Buy
138,356
+106,938
+340% +$784K 0.01% 1110
2013
Q2
$202K Buy
+31,418
New +$202K ﹤0.01% 1633